Cargando…
Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease
Mitochondrial quality control is essential for the long-term survival of postmitotic neurons. The E3 ubiquitin ligase Parkin promotes the degradation of damaged mitochondria via mitophagy and mutations in Parkin are a major cause of early-onset Parkinson’s disease (PD). Surprisingly however, mice de...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547682/ https://www.ncbi.nlm.nih.gov/pubmed/33037272 http://dx.doi.org/10.1038/s41598-020-73854-y |
_version_ | 1783592470966173696 |
---|---|
author | Hollville, Emilie Joers, Valerie Nakamura, Ayumi Swahari, Vijay Tansey, Malú G. Moy, Sheryl S. Deshmukh, Mohanish |
author_facet | Hollville, Emilie Joers, Valerie Nakamura, Ayumi Swahari, Vijay Tansey, Malú G. Moy, Sheryl S. Deshmukh, Mohanish |
author_sort | Hollville, Emilie |
collection | PubMed |
description | Mitochondrial quality control is essential for the long-term survival of postmitotic neurons. The E3 ubiquitin ligase Parkin promotes the degradation of damaged mitochondria via mitophagy and mutations in Parkin are a major cause of early-onset Parkinson’s disease (PD). Surprisingly however, mice deleted for Parkin alone are rather asymptomatic for PD-related pathology, suggesting that other complementary or redundant mitochondrial quality control pathways may exist in neurons. Mitochondrial damage is often accompanied by the release of toxic proteins such as cytochrome c. We have reported that once in the cytosol, cytochrome c is targeted for degradation by the E3 ligase CUL9 in neurons. Here we examined whether CUL9 and Parkin cooperate to promote optimal neuronal survival in vivo. We generated mice deficient for both Cul9 and Parkin and examined them for PD-related phenotypes. Specifically, we conducted assays to examine behavioural deficits (locomotor, sensory, memory and learning) and loss of dopaminergic neurons in both males and females. Our results show that the loss of Cul9 and Parkin together did not enhance the effect of Parkin deficiency alone. These results indicate that while both Parkin and CUL9 participate in mitochondrial quality control, neurons likely have multiple redundant mechanisms to ensure their long-term survival. |
format | Online Article Text |
id | pubmed-7547682 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75476822020-10-14 Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease Hollville, Emilie Joers, Valerie Nakamura, Ayumi Swahari, Vijay Tansey, Malú G. Moy, Sheryl S. Deshmukh, Mohanish Sci Rep Article Mitochondrial quality control is essential for the long-term survival of postmitotic neurons. The E3 ubiquitin ligase Parkin promotes the degradation of damaged mitochondria via mitophagy and mutations in Parkin are a major cause of early-onset Parkinson’s disease (PD). Surprisingly however, mice deleted for Parkin alone are rather asymptomatic for PD-related pathology, suggesting that other complementary or redundant mitochondrial quality control pathways may exist in neurons. Mitochondrial damage is often accompanied by the release of toxic proteins such as cytochrome c. We have reported that once in the cytosol, cytochrome c is targeted for degradation by the E3 ligase CUL9 in neurons. Here we examined whether CUL9 and Parkin cooperate to promote optimal neuronal survival in vivo. We generated mice deficient for both Cul9 and Parkin and examined them for PD-related phenotypes. Specifically, we conducted assays to examine behavioural deficits (locomotor, sensory, memory and learning) and loss of dopaminergic neurons in both males and females. Our results show that the loss of Cul9 and Parkin together did not enhance the effect of Parkin deficiency alone. These results indicate that while both Parkin and CUL9 participate in mitochondrial quality control, neurons likely have multiple redundant mechanisms to ensure their long-term survival. Nature Publishing Group UK 2020-10-09 /pmc/articles/PMC7547682/ /pubmed/33037272 http://dx.doi.org/10.1038/s41598-020-73854-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Hollville, Emilie Joers, Valerie Nakamura, Ayumi Swahari, Vijay Tansey, Malú G. Moy, Sheryl S. Deshmukh, Mohanish Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title | Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title_full | Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title_fullStr | Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title_full_unstemmed | Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title_short | Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease |
title_sort | characterization of a cul9–parkin double knockout mouse model for parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547682/ https://www.ncbi.nlm.nih.gov/pubmed/33037272 http://dx.doi.org/10.1038/s41598-020-73854-y |
work_keys_str_mv | AT hollvilleemilie characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT joersvalerie characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT nakamuraayumi characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT swaharivijay characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT tanseymalug characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT moysheryls characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease AT deshmukhmohanish characterizationofacul9parkindoubleknockoutmousemodelforparkinsonsdisease |